- If you have a family history of breast cancer, the right screening plan depends on your age, symptoms, breast density, the number of affected relatives, their age at diagnosis, and whether a known inherited gene mutation is present.
- Mammography remains the main breast screening test for many women. Breast ultrasound is useful for breast lumps, focal pain, dense breast tissue and targeted assessment. Breast MRI is often used for very high-risk patients, especially those with BRCA1, BRCA2, PALB2 or TP53 mutations.
Family History of Breast Cancer: What It Means and Which Screening Tests You May Need
When your GP or a breast specialist asks about your family history, they are talking about your blood relatives, not in‑laws or close friends.
This includes both sides of the family, your mother’s side and your father’s side. Parents, brothers and sisters, children, grandparents, aunts, uncles, cousins, nieces and nephews can all be relevant.
It is easy to assume that only the women in the family “count”, but that is not accurate since male relatives matter too.
A father, brother or uncle with breast cancer is important to flag clearly because breast cancer in men is rare and can point to an inherited gene change running through the family.
And the timing also matters. If one relative was diagnosed later in life, say in their sixties or seventies, and no one else in the family has had breast or ovarian cancer, your risk is usually only slightly higher than average.
The picture changes when several relatives are affected, when diagnoses happen at a younger age, or when breast and ovarian cancers show up across different branches of the same family. These patterns are what move someone from near‑population risk into a moderate or high‑risk group.
We’re going into detail about this in this article and everything you need to know about family history of breast cancer and what you need to do in that case.
How much does family history raise your breast cancer risk?
Having a relative with breast cancer changes your odds. It does not decide them.
Large UK studies show that women with a first‑degree relative, meaning a mother, sister or daughter, with breast cancer have roughly double the risk of women with no affected first‑degree relatives.
While the number can sound alarming, it is important to know that even in this higher risk group, most women still go through life without ever developing breast cancer.
Your risk tends to rise further when:
- Two or more close relatives are affected
- A relative was diagnosed before about age 40 to 50
- A male relative has had breast cancer
- Breast and ovarian cancers both appear in the same branch of the family
- A relative carries a known high‑risk gene change such as BRCA1 or BRCA2
Because these patterns can get complicated once you add cousins, half‑siblings and relatives on your father’s side, UK breast clinics rarely rely on one relative’s story alone.
Instead, they use structured family history questionnaires alongside breast cancer risk calculators, such as Tyrer‑Cuzick or BOADICEA/CanRisk, to work out an estimated lifetime risk.
These tools take into account how many relatives are affected, the ages at diagnosis, your own hormonal and reproductive history and sometimes breast density. The result is a personalised risk estimate rather than a rough guess.
Why Breast Cancer Can Run in Families: Family history and breast cancer genes
In most families, breast cancer develops from a combination of ageing, hormone exposure, breast density and lifestyle factors, rather than a single gene fault.
A smaller group of families carry inherited changes in genes that normally help cells repair damaged DNA. The most well‑known include:
- BRCA1 and BRCA2, high‑risk genes that significantly raise the chance of breast and ovarian cancer and can be linked to other cancers as well.
- PALB2, which works with BRCA2 in DNA repair. Some PALB2 changes can push lifetime breast cancer risk into a similar range as BRCA2.
- TP53, linked to Li‑Fraumeni syndrome, a rare condition associated with several early‑onset cancers including breast cancer.
- CHEK2, ATM and other moderate‑risk genes that can contribute to clusters of breast cancer in families, usually with lower risk than BRCA1 or BRCA2.
If a gene change like BRCA runs in a family, not every relative will inherit it.
Genetic testing is what tells the difference between a person who truly carries a high‑risk gene and someone whose inherited risk is closer to the general population.
It’s also important to know that genetic testing is not automatically offered just because one relative has had breast cancer.
It is usually recommended when the overall pattern in the family points clearly towards an inherited cause: early diagnoses, several affected relatives, male breast cancer or a combination of breast and ovarian cancers.
Knowing your family history helps you and your clinician decide how closely to watch for changes, but it isn’t a substitute for getting a current symptom checked properly.
If you’ve noticed a lump, a nipple change, breast pain, a skin change, or anything else that feels different right now, the One Stop Breast Clinic is built to get you a clear answer without unnecessary delay.
Near‑population, moderate and high‑risk groups: Why the difference matters
To make sense of different family patterns, UK breast and genetics clinics group people into three main categories: near‑population risk, moderate risk and high risk.
Near‑population (or “general”) risk
This usually applies if you have one female relative over 40 with breast cancer, with no male breast cancer, no ovarian cancer and no clear clustering. Your risk sits close to that of the general population for your age. Current NHS breast screening guidance offers mammograms every three years between 50 and 70 in this group.
Moderate familial risk
This group includes a modest cluster, for example two close relatives with breast cancer diagnosed at typical ages, or one relative with breast cancer plus a limited number of related cancers. Lifetime risk is higher than average, but it is still more likely than not that you will never develop breast cancer. Women in this category are often offered earlier or more frequent mammograms, for example yearly from about 40 to 49.
High or very high risk
This applies when there is strong clustering across the family, early diagnoses, male breast cancer, both breast and ovarian cancers, bilateral breast cancer (cancer in both breasts), or a confirmed high‑risk gene mutation such as BRCA1, BRCA2, PALB2 or TP53. Lifetime risk in this group can be several times higher than the general population.
Annual mammography and sometimes MRI may be recommended from a younger age, alongside conversations about risk‑reducing medication and, in some cases, surgery.
Being placed into a moderate or high‑risk group is not a diagnosis and it does not mean breast cancer is on its way. It means your team has enough information to build a screening and monitoring plan that matches your real risk rather than leaving things to chance.